Anemia and Risk Factors in HAART Naïve and HAART Experienced HIV Positive Persons in South West Ethiopia: A Comparative Study

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Gedefaw, Lealem ^a   Yemane, Tilahun ^a   Sahlemariam, Zewdineh ^a   Yilma, Daniel ^a  

^a JIMMA UNIVERSITY   (Ethiopia)

Author keywords

[No Author keywords available]

Indexed keywords

EFAVIRENZ; LAMIVUDINE; NEVIRAPINE; STAVUDINE; TENOFOVIR; ZIDOVUDINE;

ADOLESCENT; ADULT; ANEMIA; ARTICLE; BLOOD; BLOOD CELL COUNT; BLOOD SMEAR; CD4 LYMPHOCYTE COUNT; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; ETHIOPIA; FECES; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INTESTINE PARASITE; MAJOR CLINICAL STUDY; MALARIA; MALE; PREDICTION; PRESCHOOL CHILD; PREVALENCE; QUESTIONNAIRE; RISK FACTOR; SCHOOL CHILD; SOCIAL ASPECT; TREATMENT DURATION; COMPLICATION; DRUG EFFECTS; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS 1; LONGITUDINAL STUDY; MIDDLE AGED; NEWBORN; PATHOPHYSIOLOGY; SOCIAL CLASS; VIROLOGY;

ADOLESCENT; ADULT; ANEMIA; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT; INFANT, NEWBORN; LAMIVUDINE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEVIRAPINE; QUESTIONNAIRES; RISK FACTORS; SOCIAL CLASS; ZIDOVUDINE;

EID: 84881575885     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072202     Document Type: Article

References (14)

1. Owiredu W, Quaye L, Amidu N, Addai-Mensah O, (2011) Prevalence of anaemia and immunological markers among Ghanaian HAART-naive HIV-patients and those on HAART. African Health Sciences 11(1): 2-15.
2. Sara J, Amitis R, Duman S, Banafsheh MB, SeyedAhmad S, et al. (2009) A Cross-Sectional study of anemia in Human Immunodeficiency Virus-Infected patients in Iran. Arch Iranian Med 12 (2): 145-150.
3. Karen S (2009) The multifactorial burden of anemia in Africa. S Afr Med J 99(12).
4. Patrick S, Debra L, Susan Y, Jeffrey L, John W, et al. (1998) Epidemiology of anemia in Human Immunodeficiency Virus (HIV) infected persons: Results from the multistate adult and adolescent spectrum of HIV disease surveillance project. Blood 91(1): 301-308.
5. Evans R, Scadden D, (2000) Hematological aspects of HIV infection. Baillieres Best Pract Res 13(2): 215-30.
6. Jose A, Jesus E, Rosa E, Carla I, Jose L, et al. (2010) Risk factors and correlates for anemia in HIV treatment-naïve infected patients: across-sectional analytical study. Biomed Central 3(230).
7. Smith JR, (2010) The clinical and economic Burden of Anemia. Am J Manag Care 16: 59-66.
8. Worldwide prevalence of anaemia 1993-2005 (2008). WHO global database on anemia. World Health Organization.
9. Mugisha J, Shafer L, Van der Paal L, Mayanja B, Eotu H, et al. (2008) Anemia in a rural Ugandan HIV cohort: prevalence at enrolment, incidence, diagnosis and associated factors. Trop Med Int Health 13(6): 788-94.
10. Byomakesh D, Ajay W, Ravinder K, Aman S, Reena D (2009) Profile of hematological abnormalities of Indian HIV infected individuals. BMC blood Disorders 9(5).
11. Omoregie R, Egbeobauwaye A, Ogefere H, Omokaro EU, Ekeh CC (2009) Prevalence of anemia among HIV-infected patients in Benin City, Nigeria. Tanzania Journal of Health Research 11 (1).
12. Mildvan D, Terri C, Gerhard L, (2007) Anemia prevalence and correlation with biomarkers and ART in HIV/AIDS. Current Medical Research and Opinion 23(2): 343-355.
13. Richard DM, Darrell F (2002) Anemia in HIV-infected patients receiving highly active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes 29(1).
14. Asgeir Johannessen, Ezra Naman, Svein Gundersen, Johan Bruun (2011) Antiretroviral treatment reverses HIV-associated anemia in rural Tanzania. BMC Infect Dis 11(190).